Consolidated Statements of Changes in Shareholders' Deficit - USD ($) shares in Millions, $ in Millions		Total	Common Stock	Additional Paid-in Capital	Retained Losses	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2020			0.0
Beginning balance at Dec. 31, 2020		$ (867.2)	$ 0.0	$ 622.8	$ (360.5)	$ (1,133.8)	$ 4.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(63.9)			(63.6)		(0.3)
Other comprehensive income (loss)		(43.3)				(43.3)
Exercise/ vesting/ expense of share-based compensation		0.6		0.6
Ending balance (in shares) at Mar. 31, 2021	[1]		0.0
Ending balance at Mar. 31, 2021	[1]	(973.8)	$ 0.0	623.4	(424.1)	(1,177.1)	4.0
Beginning balance (in shares) at Dec. 31, 2020			0.0
Beginning balance at Dec. 31, 2020		(867.2)	$ 0.0	622.8	(360.5)	(1,133.8)	4.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(169.1)
Other comprehensive income (loss)		(19.9)
Ending balance (in shares) at Sep. 30, 2021	[1]		0.0
Ending balance at Sep. 30, 2021	[1]	(898.5)	$ 0.0	632.1	(379.8)	(1,153.5)	2.7
Beginning balance (in shares) at Mar. 31, 2021	[1]		0.0
Beginning balance at Mar. 31, 2021	[1]	(973.8)	$ 0.0	623.4	(424.1)	(1,177.1)	4.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(62.1)			(61.6)		(0.5)
Other comprehensive income (loss)		32.2				32.1	0.1
Exercise/ vesting/ expense of share-based compensation		4.2		4.2
Ending balance (in shares) at Jun. 30, 2021	[1]		0.0
Ending balance at Jun. 30, 2021	[1]	(999.5)	$ 0.0	627.6	(485.7)	(1,145.0)	3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale on Avon Luxembourg	[2]	148.4			148.4
Net (loss) income		(43.1)			(42.5)		(0.6)
Other comprehensive income (loss)		(8.8)				(8.5)	(0.3)
Exercise/ vesting/ expense of share-based compensation		4.5		4.5
Ending balance (in shares) at Sep. 30, 2021	[1]		0.0
Ending balance at Sep. 30, 2021	[1]	(898.5)	$ 0.0	632.1	(379.8)	(1,153.5)	2.7
Beginning balance (in shares) at Dec. 31, 2021			0.0
Beginning balance at Dec. 31, 2021		(854.7)	$ 0.0	631.2	(404.2)	(1,085.5)	3.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(97.0)			(97.2)		0.2
Other comprehensive income (loss)		52.2				52.3	(0.1)
Exercise/ vesting/ expense of share-based compensation		2.4		2.4
Ending balance (in shares) at Mar. 31, 2022	[3]		0.0
Ending balance at Mar. 31, 2022	[3]	(897.1)	$ 0.0	633.6	(501.4)	(1,033.2)	3.9
Beginning balance (in shares) at Dec. 31, 2021			0.0
Beginning balance at Dec. 31, 2021		(854.7)	$ 0.0	631.2	(404.2)	(1,085.5)	3.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(296.0)
Other comprehensive income (loss)		95.8
Ending balance (in shares) at Sep. 30, 2022	[3]		0.0
Ending balance at Sep. 30, 2022	[3]	(1,049.9)	$ 0.0	636.3	(700.4)	(989.0)	3.2
Beginning balance (in shares) at Mar. 31, 2022	[3]		0.0
Beginning balance at Mar. 31, 2022	[3]	(897.1)	$ 0.0	633.6	(501.4)	(1,033.2)	3.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(75.0)			(74.9)		(0.1)
Other comprehensive income (loss)		15.6				15.9	(0.3)
Exercise/ vesting/ expense of share-based compensation		0.6		0.6
Ending balance (in shares) at Jun. 30, 2022	[3]		0.0
Ending balance at Jun. 30, 2022	[3]	(955.9)	$ 0.0	634.2	(576.3)	(1,017.3)	3.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(124.0)			(124.1)		0.1
Other comprehensive income (loss)		27.9				28.3	(0.4)
Exercise/ vesting/ expense of share-based compensation		2.1		2.1
Ending balance (in shares) at Sep. 30, 2022	[3]		0.0
Ending balance at Sep. 30, 2022	[3]	$ (1,049.9)	$ 0.0	$ 636.3	$ (700.4)	$ (989.0)	$ 3.2

[1] The number of shares of Common Stock (par value $0.01 per share) outstanding at September 30, 2021 was 101.34.

[2] On July 1, 2021, the Company sold Avon Luxembourg and its subsidiaries, including our Mexican business, to a subsidiary of Natura &Co Holding S.A. for $150. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale, and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings.

[3] The number of shares of Common Stock (par value $0.01 per share) outstanding at September 30, 2022 was 101.34.